ID   CaLo
AC   CVCL_5121
SY   CALO
DR   BTO; BTO_0003110
DR   cancercelllines; CVCL_5121
DR   GEO; GSM722570
DR   GEO; GSM722571
DR   GEO; GSM723051
DR   GEO; GSM723052
DR   Progenetix; CVCL_5121
DR   SKY/M-FISH/CGH; 2648
DR   Wikidata; Q54808421
RX   CelloPub=CLPUB00348;
RX   CelloPub=CLPUB00743;
RX   PubMed=12659655;
RX   PubMed=22412903;
RX   PubMed=35692560;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
RX   CelloPub=CLPUB00348;
RA   Rangel-Corona R., Ramirez-Gaytan J.L., Rocha-Zavaleta L.,
RA   Solorza-Luna G., Monroy-Garcia A., Martinez-Perez R.D.,
RA   Trejo-Becerril C., de Jesus Ibarra-Sanchez M., Weiss-Steider B.;
RT   "Establishment and characterization of a cell line (CaLo) and a clone
RT   (KaLo), obtained from a cervix carcinoma and the effect of IL-2, IL-3,
RT   GM-CSF, M-CSF, TNF-alpha and IFN-gamma on its proliferation.";
RL   Rev. Inst. Nac. Cancerol. (Mex.) 39:1861-1866(1993).
//
RX   CelloPub=CLPUB00743;
RA   Monroy-Garcia A., Rangel-Corona R., Rocha-Zavaleta L.,
RA   Trejo-Becerril C., Ramirez-Gaytan J.L., Martinez-Perez R.D.,
RA   Weiss-Steider B.;
RT   "Desmoglein-1 contents and location of seven cell lines of normal
RT   cervix uteri and uterine cervix cancer.";
RL   Rev. Mex. Oncol. 7:69-76(1992).
//
RX   PubMed=12659655; DOI=10.1186/1471-2407-3-8; PMCID=PMC153511;
RA   Hidalgo A., Monroy-Garcia A., Arana R.M., Taja L., Vazquez G.,
RA   Salcedo M.;
RT   "Chromosomal imbalances in four new uterine cervix carcinoma derived
RT   cell lines.";
RL   BMC Cancer 3:8.1-8.5(2003).
//
RX   PubMed=22412903; DOI=10.1371/journal.pone.0032667; PMCID=PMC3296745;
RA   Vazquez-Mena O., Medina-Martinez I., Juarez-Torres E., Barron V.,
RA   Espinosa A., Villegas-Sepulveda N., Gomez-Laguna L.,
RA   Nieto-Martinez K., Orozco L., Roman-Bassaure E., Munoz Cortez S.,
RA   Borges Ibanez M., Venegas-Vega C.A., Guardado-Estrada M.,
RA   Rangel-Lopez A., Kofman S., Berumen J.;
RT   "Amplified genes may be overexpressed, unchanged, or downregulated in
RT   cervical cancer cell lines.";
RL   PLoS ONE 7:e32667.1-e32667.17(2012).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez M., Lopez-Mendoza C.M., Tenorio-Salazar J.,
RA   Garcia-Carranca A.M., Cerbon-Cervantes M.A., Alcantara-Quintana L.E.;
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//